S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Blissful Essence Brings EXOMIND Brain Therapy to Springfield

Springfield residents now have access to noninvasive brain stimulation technology as Blissful Essence Wellness Center launches the region’s first EXOMIND treatment. The facility, which opened its doors on June 16, integrates advanced neurological support with aesthetic services to address the physical and emotional well-being of its clients.

Blissful Essence Brings EXOMIND Brain Therapy to Springfield
Photo: Bio & News

Developed by BTL, EXOMIND utilizes targeted magnetic pulses to assist with emotional regulation, cognitive performance, and symptoms of depression. Dr. Hitekshya Nepal, a psychiatrist and co-owner of the center, noted that the technology offers a necessary alternative or complement to traditional psychiatric care. The clinic operates as an extension of TH Mental Health Services, aiming to bridge the gap between clinical mental health treatment and restorative aesthetic procedures.

Beyond neurological services, the center provides a broad spectrum of care, including body contouring, red light therapy, IV vitamin infusions, and GLP-1 weight loss protocols. Dr. Tola Danmole-Odimayo, co-owner and DNP, emphasized that the practice seeks to provide a unified environment for patients to address appearance and health simultaneously. To mark the official opening, the clinic will host a public event on June 29 at 2041 W Iles Ave, featuring facility tours and live demonstrations of the new technology.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!